Instructions for authors
Clinical and Translational Allergy is a peer reviewed open access journal aiming to provide a platform to publish original research and reviews in the field of allergy. Such articles can be based on clinical, translational or basic research.
Clinical and Translational Allergy is one of several journals in the portfolio of the European Academy of Allergy and Clinical Immunology, and is one of the first open access journals in this field. Open access publishing enables free access to all contents ensuring a wide dissemination of articles; the electronic format and the optimised manuscript handling process allows very rapid publication of papers.
Clinical and Translational Allergy is an international journal reaching out far beyond the borders of Europe, and invites clinicians and researchers from all countries of the world to contribute. Clinical and Translational Allergy publishes original research articles and reviews, as well as EAACI position articles, EAACI Task Force Reports and EAACI guidelines.
Each article type published by Clinical and Translational Allergy follows a specific format, as detailed in the corresponding instructions for authors; please choose an article type from the list on the left to view the instructions for authors.
The instructions for authors includes information about preparing a manuscript for submission to Clinical and Translational Allergy, criteria for publication and the online submission process. Other relevant information about the journal's policies, the refereeing process and so on can be found in 'About this journal'.
Presubmission enquiries
We strongly encourage you to contact the editors with a presubmission enquiry about the suitability of your manuscript. Please email the editors who will respond to your enquiry as soon as possible.
Clinical and Translational Allergy publishes the following article types:
Authors and referees are asked to declare any competing interests.
Copyright rests with the authors. For more information on copyright of articles, see our publisher's copyright and license policy.